What is Xultophy, and does it have patents?
Xultophy is a diabetes medicine that combines insulin degludec and liraglutide. It is marketed as a fixed-dose combination product, so patent coverage typically covers multiple layers: the specific combination, dosing/titration methods, and the underlying molecules.
However, the exact patent numbers, owners, filing dates, and expiry dates depend on the country/jurisdiction and on which patent family (composition-of-matter vs. method-of-use) you mean by “Patent Xultophy.”
If you tell me the country (e.g., US, EU/EP, UK, Canada, Japan) or share a patent number you already found, I can pinpoint the relevant patents and dates.
Which “Xultophy patents” matter most for generics and biosimilars?
For diabetes fixed-dose combinations like Xultophy, the patents that matter for competition usually fall into these categories:
- Composition/combination protection (covering the combined fixed-dose formulation and/or specific combination)
- Method-of-use patents (for example, specific titration or treatment regimens)
- Data/exclusivity protections (regulatory exclusivity that can delay entry even when some patents expire)
In practice, even if one element expires, other patents can still block substitution or marketing of a competing fixed-dose product.
When would Xultophy’s patent/exclusivity expire?
“Patent expiry” is jurisdiction-specific and also depends on the patent family’s filing and priority dates, plus any adjustments (some countries allow term adjustments). There is also often a separate regulatory exclusivity timeline.
To answer with accuracy, I need:
1) jurisdiction (US/EU/UK/etc.), and
2) whether you want patent expiry or regulatory exclusivity (or both).
Are there specific patents you can look up for Xultophy?
Yes, but the lookup is easiest if we target a specific identifier. If you provide any of the following, I can narrow to the exact patents and summarize what each one covers:
- a patent number (e.g., US######## or EP########)
- a link to the patent database page you saw
- the jurisdiction you care about
Why would someone search “Xultophy patent” (what are the typical goals)?
People usually search for Xultophy patents to:
- estimate when a competitor could market a similar fixed-dose combination
- understand whether biosimilars/insulin + GLP-1 combinations could be used commercially before full expiry
- track ongoing patent litigation or patent challenges
If you tell me your goal (e.g., “when can a generic enter” vs “what patents exist”), I’ll tailor the answer.
---
Quick clarification (so I can give a precise answer)
Which jurisdiction and what do you mean by “Patent Xultophy”?
- US, EU/EP, UK, Canada, or another country?
- Do you mean a specific patent number/family, or the overall timeline for Xultophy’s patent and exclusivity protection?